BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 31, 2003
View Archived Issues
Cardioprotective effects of cariporide in pig model of limited ischemia/reperfusion
Read More
Drug pipeline for osteoarthritis
Read More
Antiinflammatory effects of montelukast in cystic fibrosis
Read More
Rosuvastatin superior to pravastatin or simvastatin in hypercholesterolemia trial
Read More
Immunomodulatory effects of WY-14643 demonstrated in mice
Read More
Antidepressant-like changes induced by SAMe in the brain of elderly volunteers
Read More
Novel glucose- and lipid-lowering agents in early development at Kyoto Pharmaceutical
Read More
Fujisawa describes dual adenosine A1/A2A antagonists for depression, dementia, etc.
Read More
Janssen presents novel agents for lowering intracranial pressure
Read More
New 5-HT6 antagonists with utility in obesity, NIDDM and CNS disorders
Read More
Schering presents new inhibitors of CDK and/or GSK-3
Read More
Recent Tanabe Seiyaku patent covers novel inhibitors of apo B secretion
Read More
Apoptosis-inducing glucose derivatives prepared and tested by Nisshin Seifun and Kyorin team
Read More
Medarex and diaDexus form antibody therapeutic collaboration
Read More
Tularik reports recent clinical highlights
Read More
Safety of ThGRF demonstrated in patients with type 2 diabetes
Read More
Replicon NeuroTherapeutics awarded grant for replicon development
Read More
Pharmexa reprioritizes programs
Read More
Kaleidos's TGF-alpha to be studied for AIDS by NIAID
Read More
Encouraging results reported for SomatoKine in adolescent type 1 diabetics
Read More
EDEMA1 trial for DX-88 in hereditary angioedema begins patient treatment
Read More
Phase II study to evaluate Aptosyn combination regimen in prostate cancer
Read More
Study suggests Active Biotech's TASQ drug is suitable for oral dosing
Read More
MBI-594AN enters phase IIb for treatment of acne
Read More
Complete response letter issued for MedImmune's intranasal flu vaccine
Read More
Calpastatin overexpression prevents myocardial injury in rat transplant model
Read More